SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community buzzes about its significant partnership with World Liberty Financial for USD1 payroll integration and ongoing discussions for potential collaborations with Ripple and Stellar. Investors are highlighting ZBCN's real-world utility in payments, near-complete token supply distribution, and the anticipated SuperApp launch as key drivers for substantial future growth. This positions Zebec as a compliant, foundational payment solution poised for broad adoption within the crypto space.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is capturing attention as an "OG privacy coin" amid discussions about its rumored collaboration with POL and recent integration with ACH, signaling expanded utility. The community is actively observing its movements, with many anticipating significant upside and comparing its potential to recent rallies in other privacy tokens like Zcash, fueled by its low market cap and scarce supply.

The ticket is $Testicle. EVERY SINGLE ONE OF YOU CAME FROM A $Testicle. $Testicle always bounce.   We have a website on which you can create art or memes. We have a community. We have a raid group. We aim to provide the best testicular care on CT.   We might even have to call on our nefarious leader, Harry Bolz. Alright Chad, SACK TF. Or else you’re a Low T beta male.   If you have questions and or concerns please feel to reach out to a team member on how you can acquire or become a high testosterone male in a sea of betas. I mean how else does one live if not as a High T male?

Testicle

TESTICLE CRYPTO is trending due to its provocative name and status as a new meme coin, drawing significant, often humorous, attention from the crypto community. Many are discussing it with a mix of ironic 'all-in' statements and comparisons to other similarly themed tokens like $BALLSACK, while others express disbelief and question the overall direction of the altcoin market. This token embodies the ongoing debate and fascination with the rapidly evolving and often outlandish meme cryptocurrency sector.

Alchemy Pay

Alchemy Pay (ACH) is trending amid significant expansion in its payment gateway capabilities, driven by new integrations like Ripple's RLUSD stablecoin and securing additional U.S. Money Transmitter Licenses. The community is buzzing about its strategic pivot to a stablecoin-centric Layer-1 blockchain and its growing suite of compliant fiat-to-crypto on-ramps, positioning ACH as a vital bridge between traditional finance and the Web3 ecosystem.

Kaspa was fair-launched in November 2021 with no pre-mine, zero pre-sale, and no coin allocations, and is 100 percent community-managed. Kaspa aims to be the world's global sequencer for traditional finance and decentralized crypto markets by utilizing proof-of-work and its BlockDAG consensus protocol, GHOSTDAG. Being the world's fastest proof-of-work network, Kaspa combines five properties: (1) hard money principles, (2) Bitcoin's ethos of security-first fundamentals (boasting a security threshold of fifty percent with significant market hashrate), (3) decentralization from rapid block rate mining, (4) block speeds faster than any PoW or PoS network, and (5) smart contract development through based-rollups without fragmented liquidity. Ushering in all five properties, Kaspa is on track to fulfill Satoshi Nakamoto's vision of a digital medium of exchange while also advancing global layer-one sequencing and minuscule confirmation times dominated by internet latency (cf. chapter 6 of the the paper for some initial benchmarks). The Kaspa implementation includes a lot of cool features and subprotocols including Reachability to query the DAG's topology, Block data pruning (with near-future plans for block header pruning), SPV proofs, and later subnetwork support which will make future implementation of layer 2 solutions much easier.

Kaspa

Kaspa is trending amid fervent community discussion surrounding its imminent smart contract launch and anticipated Tier-1 exchange listings. While many are bullish on its high-speed, secure BlockDAG technology and deflationary model, recent price volatility has fueled a divide between long-term holders and critics questioning its immediate adoption and market performance.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is trending due to mixed reactions surrounding its recent earnings, where the discontinuation of a pain drug program briefly overshadowed solid financial performance and a robust pipeline. Despite this, community conversation is heavily focused on the promising advancements in its kidney and Type 1 Diabetes programs, alongside the growing adoption of its gene therapy, Casgevy. Analysts and investors are increasingly highlighting the company's long-term growth potential, anticipating further catalysts from its diversified portfolio.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is highly active amidst a recent short report from Culper Research alleging widespread use of "unauthorized workers," sparking intense community debate and potential regulatory concerns. This controversy is juxtaposed with the company's strategic moves into autonomous delivery partnerships with Waymo and Serve Robotics, alongside significant insider share purchases, driving mixed investor sentiment regarding its long-term growth and spending initiatives.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is attracting significant attention following recent acquisitions of new anticoagulant assets and progress in manufacturing its lead candidate, tecarfarin, which is supported by a collaboration with Abbott for its Phase 3 trial. The community is sharply divided, with proponents highlighting the low float and potential market opportunity for tecarfarin in rare cardiovascular conditions, while critics frequently raise concerns about ongoing dilution and cash burn.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending due to widespread community speculation about an imminent major partnership or acquisition, with large pharmaceutical companies keenly eyeing its lead oncology asset, CAN-2409. This heightened conversation is fueled by its promising clinical data, special FDA designations, and recent regulatory flexibility, aligning with the biopharmaceutical sector's increasing M&A activity driven by impending patent expirations.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The 'MullenArmy' crypto token is trending, largely driven by community discussions linking it to the controversial Mullen Automotive stock, known for its history of reverse splits and investor lawsuits. While a faction attempts to rally support for a potential surge and claims of utility, the broader sentiment remains highly skeptical, with many users branding it as a 'scam' or 'rug pull' that echoes the stock's problematic past.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stephens Investment Management Group LLC Sells 16,431 Shares of Ambarella, Inc. $AMBA

Stephens Investment Management Group LLC cut its holdings in Ambarella, Inc. (NASDAQ:AMBA - Free Report) by 3.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm...

Ambarella (NASDAQ:AMBA) Trading 7% Higher - Time to Buy?

Ambarella (NASDAQ:AMBA) Trading Up 7% - What's Next...

An Ambarella Insider Just Sold 7,728 Shares. Here's What Investors Should Know

Key PointsA senior vice president at Ambarella sold 7,728 shares of the company for $584,105.42 on Jan. 5...

Implied Volatility Surging for Ambarella Stock Options

Investors need to pay close attention to AMBA stock based on the movements in the options market lately.

NVTS Surges 54% in 6 Months: Should You Hold or Fold the Stock?

Navitas Semiconductor shares surge more than 50% in six months on AI data-center optimism, but a rich valuation is raising hold-or-fold questions.

Ambarella CES Investor Update: CV7 4nm Samples, 2nm Tape-Out, and a Bigger Edge AI Push

Ambarella (NASDAQ:AMBA) used its CES briefing to outline an expanded edge AI strategy, introduce new silicon and software milestones, and describe a shift in go-to-market execution aimed at scaling...

Ambarella (NASDAQ:AMBA) VP Chi-Hong Ju Sells 3,765 Shares

Ambarella, Inc. (NASDAQ:AMBA - Get Free Report) VP Chi-Hong Ju sold 3,765 shares of the stock in a transaction that occurred on Tuesday, December 30th. The shares were sold at an average price of...

Chi-Hong Ju Sells 3,765 Shares of Ambarella (NASDAQ:AMBA) Stock

Ambarella, Inc. (NASDAQ:AMBA - Get Free Report) VP Chi-Hong Ju sold 3,765 shares of Ambarella stock in a transaction on Tuesday, December 30th. The stock was sold at an average price of $70.32, for a...

Ambarella (NASDAQ:AMBA) Director Christopher Paisley Sells 500 Shares

Ambarella, Inc. (NASDAQ:AMBA - Get Free Report) Director Christopher Paisley sold 500 shares of the company's stock in a transaction that occurred on Friday, December 26th. The shares were sold at an...

Christopher Paisley Sells 500 Shares of Ambarella (NASDAQ:AMBA) Stock

Ambarella, Inc. (NASDAQ:AMBA - Get Free Report) Director Christopher Paisley sold 500 shares of the stock in a transaction that occurred on Friday, December 26th. The stock was sold at an average...

Ambarella, Inc. engages in the development of low-power system-on-a-chip, or SoC, semiconductors and software for edge artificial intelligence, or AI, applications. Its products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. The firm's geographical segments include Taiwan, Asia Pacific, Europe, North America other than United States and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

AMBA
Ambarella Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMBA News

AMBAAmbarella Inc